Cover Image
市場調查報告書

泰國的醫藥品市場

The Pharmaceutical Market: Thailand

出版商 Espicom Business Intelligence 商品編碼 242190
出版日期 內容資訊 英文 115 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
泰國的醫藥品市場 The Pharmaceutical Market: Thailand
出版日期: 2014年02月05日 內容資訊: 英文 115 Pages
簡介

本報告提供泰國的醫藥品市場相關資料,整體市場趨勢與相關法規,醫藥品流通管道等分析,成藥,學名藥,生物醫藥品·生技仿製藥等不同市場區隔趨勢,加上市場機會與課題,為您概述為以下內容。

目錄

摘要整理

  • 概述: Espicom 策略性分析
  • 概述: 主要資料預測

宏觀環境

  • 政治環境
  • 經濟環境
  • 法環境
  • 人口統計

免疫學

  • 疾病的負擔
  • 得病率

所附之醫療保健統計

  • 組織·機構
  • 醫療費
  • 基礎設施
  • 服務
  • 人力資源

法規相關資訊

  • 國際組織
  • 國內當局
  • 製造管理及品管相關標準
  • 市場登記
  • 推銷

決定價格及給付

  • 價格決策

流通管道

  • 醫藥品 批發
  • 醫藥品 零售

市場分析

  • 規模
    • 預測
    • 實際成果
  • 產品開發
  • 製造
  • 貿易

競爭情形

  • 經營者團體
  • 企業資料

OTC 醫藥品

  • 市場規模
  • 競爭情形

學名藥

  • 競爭情形

生技藥品/生技仿製藥

  • 競爭情形

結論: 機會與課題

  • Espicom 策略性分析
  • 雷達分析
  • SWOT分析

相關機構、組織一覽

  • 政府組織
  • 醫藥品經銷商
  • 製藥公司
  • 藥局連鎖
  • 經營者團體

圖表


本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Abstract

Summary

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context.

The reports provide:

  • Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
  • Specialised intelligence on OTCs, generics, biologics and biosimilars.
  • Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
  • A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.

The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

Description

THE PHARMACEUTICAL MARKET: THAILAND - REVIEW

The macroenvironment is positive for the Thai pharmaceutical market. Politically, Yingluck Shinawatra became Thailand's first female Prime Minister in August 2011. Economically, the Economist Intelligence Unit (EIU) projects that Thailand will be the eighth largest economy in the Asia Pacific region by 2016. Legally, Thailand remains on the USTR's Priority Watch List in 2011. Demographically, the EIU projects an annual growth rate of around 0.7% up to 2016 and the population will be the ninth largest in the Asia Pacific region by 2016. The elderly population is rising; Thailand is expected to have the eighth highest proportion in the Asia Pacific region.

Despite relying heavily on imports, Thailand's pharmaceutical market is growing. The balance of pharmaceutical trade remains considerably negative, with retail medicaments accounting for over two-thirds of the total deficit. Between 2006 and 2010, the deficit in the balance of trade rose by a high double-digit CAGR. Thailand's pharmaceutical market is estimated to grow at a high single-digit CAGR in US dollar terms between 2011 and 2016. Thailand will have the eighth largest pharmaceutical market in the Asia Pacific region in 2016. In per capita terms, Thailand is projected to have the eighth highest rate in the Asia Pacific region by 2016.

The Thai generic sector is growing, especially in the public sector, where the government has encouraged its use over patented drugs in order to cut costs. Greater Pharma has recently launched its first generic inhaler drug for the treatment of osteoporosis, making it the first company in Southeast Asia to successfully manufacture a generic version of this drug. The Thai biologic sector is very underdeveloped, but there are signs that this could change. The government-backed organisation BIOTEC has formed partnerships with both Greater Pharma and i+MED. Greater Pharma has developed the first biologic allergy vaccine in Southeast Asia.

ENHANCED STRATEGIC INTELLIGENCE

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context.

The reports provide:

  • Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
  • Specialised intelligence on OTCs, generics, biologics and biosimilars.
  • Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
  • A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.

The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

HEALTHCARE STATISTICS

A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.

About Espicom Business Intelligence

Espicom Business Intelligence is a UK-based company with a 30-year pedigree providing business intelligence on Medical Devices, Pharmaceuticals & Healthcare and Therapeutics across global markets.

Table of Contents

Executive Summary

SWOT Analysis

  • Thailand Pharmaceutical And Healthcare Industry SWOT
  • Thailand Political SWOT
  • Thailand Economic SWOT
  • Thailand Business Environment SWOT

Pharmaceutical Risk/Reward Ratings

  • Table: Asia Pacific Pharmaceutical And Healthcare Risk/Reward Ratings, Q113
  • Rewards
  • Risks

Thailand - Market Summary

Regulatory Regime

  • Recent Regulatory Developments
  • Regional Harmonisation
  • Intellectual Property Regime
  • IP Shortcomings
  • Counterfeit Drugs
  • Compulsory Licensing
  • IP Developments
  • Pricing And Reimbursement
    • Table: Price Build-Up Of Medicines In Thailand

Industry Trends And Developments

  • Epidemiology
  • Communicable Diseases
  • Healthcare System
  • Healthcare Insurance
    • Table: Various Healthcare Scheme In Thailand
  • Medical Tourism
  • Research And Development (R&D)
  • Biosimilars
  • Clinical Trials
  • Medical Devices
  • Developments In The Medical Devices Sector

Industry Forecast Scenario

  • Overall Market Forecast
    • Table: Pharmaceutical Sales Indicators, 2008-2016
  • Healthcare Market Forecast
    • Table: Healthcare Expenditure Indicators, 2008-2016
    • Table: Healthcare Governmental Indicators, 2008-2016
    • Table: Healthcare Private Indicators, 2008-2016
  • Key Growth Factors - Macroeconomic
  • Thailand - Economic Activity
  • Prescription Drug Market Forecast
    • Table: Prescription Drug Sales Indicators, 2008-2016
  • Patented Drug Market Forecast
    • Table: Patented Drug Market Indicators, 2008-2016
  • Generic Drug Market Forecast
    • Table: Generic Drug Sales Indicators, 2008-2016
  • OTC Medicine Market Forecast
    • Table: OTC Medicine Sales Indicators, 2008-2016
    • Table: OTC Medicine Sales Indicators, 2008-2016
  • Pharmaceutical Trade Forecast
    • Table: Exports and Imports Indicators, 2008-2016
  • Medical Device Market Forecast
    • Table: Medical Devices Sales Indicators, 2008-2016
  • Other Healthcare Data
  • Key Risks To BMI's Forecasts

Competitive Landscape

  • Pharmaceutical Industry
  • Domestic Pharmaceutical Industry
    • Table: Pharmaceutical Manufacturers Of Modern Drugs, 2007-2012
    • Table: Pharmaceutical Production At Wholesale Prices, 1983-2010
  • Foreign Pharmaceutical Industry
    • Table: PReMA Members, 2012
  • Recent Pharmaceutical Industry Developments
  • Pharmaceutical Wholesale
  • Pharmaceutical Retail
    • Table: Pharmacies By Region, 2000-09

Company Profiles

  • Domestic Companies
  • Siam Pharmaceutical
  • Government Pharmaceutical Organisation (GPO)
  • Biolab
  • Thai Meiji Pharmaceutical Company
  • Berlin Pharmaceutical Industry
  • Multinational Companies
  • Pfizer
  • Sanofi
  • GlaxoSmithKline (GSK)
  • Merck & Co
  • Novartis

Demographic Data

  • THAILAND - Population By Age Group
  • THAILAND - Population By Age Group
  • THAILAND - Key Population Ratios
  • THAILAND - Rural And Urban Population

Glossary

BMI Methodology

  • How We Generate Our Pharmaceutical Industry Forecasts

Pharmaceuticals Business Environment Ratings

  • Risk/Reward Ratings Methodology
  • Ratings Overview
    • Table: Pharmaceutical Business Environment Indicators
  • Weighting
    • Table: Weighting Of Components
  • Sources
Back to Top